Skip to main content
mBio logoLink to mBio
. 2024 Mar 12;15(4):e01990-23. doi: 10.1128/mbio.01990-23

Wall teichoic acid substitution with glucose governs phage susceptibility of Staphylococcus epidermidis

Christian Beck 1,2,3, Janes Krusche 1,2,3, Anna Notaro 4, Axel Walter 1,5, Lara Kränkel 1,2,3, Anneli Vollert 6, Regine Stemmler 1,2,3, Johannes Wittmann 7, Martin Schaller 6, Christoph Slavetinsky 1,2,3,8, Christoph Mayer 1,5, Cristina De Castro 9, Andreas Peschel 1,2,3,
Editors: Tarek Msadek10, Michael Otto11
PMCID: PMC11005348  PMID: 38470054

ABSTRACT

The species- and clone-specific susceptibility of Staphylococcus cells for bacteriophages is governed by the structures and glycosylation patterns of wall teichoic acid (WTA) glycopolymers. The glycosylation-dependent phage-WTA interactions in the opportunistic pathogen Staphylococcus epidermidis and in other coagulase-negative staphylococci (CoNS) have remained unknown. We report a new S. epidermidis WTA glycosyltransferase TagE whose deletion confers resistance to siphoviruses such as ΦE72 but enables binding of otherwise unbound podoviruses. S. epidermidis glycerolphosphate WTA was found to be modified with glucose in a tagE-dependent manner. TagE is encoded together with the enzymes PgcA and GtaB providing uridine diphosphate-activated glucose. ΦE72 transduced several other CoNS species encoding TagE homologs, suggesting that WTA glycosylation via TagE is a frequent trait among CoNS that permits interspecies horizontal gene transfer. Our study unravels a crucial mechanism of phage-Staphylococcus interaction and horizontal gene transfer, and it will help in the design of anti-staphylococcal phage therapies.

IMPORTANCE

Phages are highly specific for certain bacterial hosts, and some can transduce DNA even across species boundaries. How phages recognize cognate host cells remains incompletely understood. Phages infecting members of the genus Staphylococcus bind to wall teichoic acid (WTA) glycopolymers with highly variable structures and glycosylation patterns. How WTA is glycosylated in the opportunistic pathogen Staphylococcus epidermidis and in other coagulase-negative staphylococci (CoNS) species has remained unknown. We describe that S. epidermidis glycosylates its WTA backbone with glucose, and we identify a cluster of three genes responsible for glucose activation and transfer to WTA. Their inactivation strongly alters phage susceptibility patterns, yielding resistance to siphoviruses but susceptibility to podoviruses. Many different CoNS species with related glycosylation genes can exchange DNA via siphovirus ΦE72, suggesting that glucose-modified WTA is crucial for interspecies horizontal gene transfer. Our finding will help to develop antibacterial phage therapies and unravel routes of genetic exchange.

KEYWORDS: coagulase-negative staphylococci, Staphylococcus epidermidis, wall teichoic acid, bacteriophages, glycosyltransferase

INTRODUCTION

Staphylococcus epidermidis is one of the most abundant colonizers of mammalian skin and nasal epithelia (1, 2). Some nosocomial S. epidermidis clones also cause invasive infections, in particular biofilm-associated infections on catheters or artificial implants such as hip and knee joints or heart valves (3, 4). Although S. epidermidis is not an as aggressive pathogen as Staphylococcus aureus, biofilm-associated infections are difficult to treat and cause a high burden of morbidity and costs for health care systems. Many S. epidermidis clones are resistant to beta-lactams and other antibiotics such as linezolid, which further complicates the treatment of S. epidermidis infections (1).

The major invasive S. epidermidis clones seem to pursue two different virulence strategies. The multilocus sequence type2 (ST2) strains produce particularly strong biofilms (3, 5). In contrast, ST10, ST23, and ST87 clones are only weak biofilm formers, but they express an additional surface molecule that alters their host interaction capacities and leads to a shift from commensal to pathogen behavior (6). Surface properties and host interaction of staphylococci are governed not only by surface proteins but also by cell-wall anchored glycopolymers composed of alditolphosphate-repeating units called wall teichoic acids (WTA) (7, 8). The WTA polymers of S. epidermidis and other coagulase-negative staphylococci (CoNS) species have remained a neglected field of research despite their potentially critical role for host colonization and infection. Most S. epidermidis clones seem to express WTA composed of glycerolphosphate (GroP)-repeating units (9). A recent study has shown that ST10, ST23, and ST87 strains express an additional S. aureus-type WTA composed of ribitolphosphate (RboP)-repeating units, which shapes their interaction with human epithelial and endothelial cells (6).

WTA is also crucial for the binding of virtually all known Staphylococcus phages, which use differences in WTA structure to recognize their cognate host species (10). Phages of the sipho- and podovirus groups often not only discriminate between different WTA backbones but also between different types of backbone glycosylation. Most Firmicutes link D-alanine esters and sugar residues to GroP- or RboP-repeating units (7, 8). Variation in glycosylation for instance by N-acetylglucosamine (GlcNAc) in alpha or beta configuration or N-acetylgalactosamine (GalNAc) has been found to govern the susceptibility patterns of S. aureus strains for different phages (1114). The group of broad-host range myoviruses, however, requires WTA for binding but does not discriminate between RboP and GroP WTA and does not require WTA glycosylation (1517).

WTA-phage interaction is of importance for phage-therapeutic strategies, which have gained increasing attention recently (3, 18). Moreover, they are critical for interspecies horizontal gene transfer via transducing bacteriophages (19). Such transduction events have led to the transfer of resistance and virulence genes into the genomes of S. aureus and other species, thereby allowing, for instance, the evolution of methicillin-resistant S. epidermidis (MRSE) and methicillin-resistant S. aureus (MRSA) (20, 21). Despite the critical role of WTA in these processes, the biosynthesis, composition, and glycosylation of the canonical S. epidermidis WTA has not been studied.

Here, we demonstrate that S. epidermidis strain 1457 (ST86), which has been isolated from a central venous catheter infection (22), glycosylates its GroP-WTA with glucose, and we identify the WTA glucosyltransferase gene tagE. S. epidermidis tagE mutants showed complex changes in phage susceptibility patterns including both the loss and the acquisition of susceptibility to certain phages, some of which we found to be capable of transducing plasmid DNA between different CoNS species.

RESULTS

Disruption of a putative glycosyl transferase gene cluster confers resistance to phage ΦE72

Several new phages with the capacity to infect S. epidermidis have been reported recently (23, 24). Some of them have the capacity to transduce DNA between different S. epidermidis lineages, raising the questions of which bacterial target structures are recognized by the phages’ binding proteins and how universal these target structures may be among different clones of S. epidermidis and other CoNS. As most S. aureus phages recognize the sugar modifications of WTA (1113, 25), it was tempting to speculate that glycosylated GroP-WTA is also required for the binding of S. epidermidis phages. However, the enzymes responsible for WTA glycosylation in S. epidermidis have remained unknown, and it has also remained elusive, which glycosylation patterns can be found on S. epidermidis GroP-WTA. To elucidate the WTA glycosylation pathways of S. epidermidis and explore its impact on phage interaction, we set out to identify and inactivate the responsible enzyme genes.

A library of transposon mutants of S. epidermidis 1457 was created using a xylose-inducible Himar1 transposase (26) and incubated with phage ΦE72, which is known to infect and multiply in strain 1457 (23). Several isolates, which were resistant to ΦE72, were identified. However, all these isolates had the transposon integrated at only two distinct positions in two adjacent genes of unknown function (Fig. 1a, 2a and d). The two genes were not in the vicinity of other WTA-biosynthesis-related genes, but their gene products shared similarities with glycosylation-related enzymes. The amino acid sequence of the gene B4U56_RS02220 product was 46% similar to TagE of Bacillus subtilis, which glycosylates GroP-WTA with glucose residues (27) and 48% similar to TarM of S. aureus, which glycosylates RboP-WTA with GlcNAc (Fig. 1b) (28). The adjacent gene B4U56_RS02215 encodes a protein with 59% similarity to the phosphoglucomutase PgcA of B. subtilis, which isomerizes glucose-6-phosphate to yield glucose-1-phosphate (29). In addition, the product of gene B4U56_RS02210, next to pgcA, was 85% similar to the GtaB enzyme of B. subtilis generating uridine diphosphate glucose (UDP-glucose) from glucose-1-phosphate and UTP (30). Both, PgcA and GtaB are required for glycosylation of GroP-WTA with glucose via TagE in B. subtilis (31), although the two genes are not encoded together with tagE in B. subtilis (32, 33). We assumed that the three enzymes might cooperate in S. epidermidis to activate and attach glucose to GroP-WTA.

Fig 1.

Fig 1

The tagE gene encodes a glycosyltransferase in S. epidermidis. (a) Genetic locus identified by transposon mutagenesis contains the S. epidermidis tagE, pgcA, and gtaB homologs. Transposon insertion sites are labeled in gold. (b) MUSCLE alignment of S. epidermidis TagE with B. subtilis TagE and S. aureus TarM protein sequences.

Fig 2.

Fig 2

Efficiency of plating (EOP) (a and b) and binding (d and e) of ΦE72 is reduced on the tagE, pgcA, and gtaB deletion mutants, compared to the S. epidermidis wild type (WT). This defect can be restored by complementing the tagE mutant with the genetic locus containing tagE, pgcA, and gtaB on plasmid pRB473 (c and f). The data represent the mean ± SEM of at least three independent experiments. Ordinary one-way analysis of variance (ANOVA) was used to determine statistical significance vs S. epidermidis 1457 WT, followed by Dunnett’s multiple comparisons tests, indicated as: not significant (ns), **P < 0.01, ***P < 0.001, and ****P < 0.0001.

S. epidermidis TagE is responsible for glucose addition to GroP-WTA

The three S. epidermidis genes were renamed according to the corresponding B. subtilis genes tagE, gtaB, and pgcA. All three genes were inactivated by targeted deletion to confirm their roles in phage susceptibility. The three deletion mutants, like the two transposon mutants, showed reduced susceptibility to ΦE72 infection, and complementation of the tagE mutant with a plasmid-encoded copy of the gene locus restored wild-type (WT) level ΦE72 susceptibility (Fig. 2c and f). The various transposon and targeted deletion mutants were approximately threefold less susceptible to ΦE72 infection but were not completely resistant, suggesting that the phage may have additional, albeit less effective, ways to interact with S. epidermidis 1457. In a similar way, and even more pronounced, the mutants had retained only limited capacities to bind ΦE72 particles in liquid media (Fig. 2d through f; Fig. S1).

WTA isolated from 1457 WT contained substantial amounts of glucose when analyzed by an enzymatic glucose assay indicating that ca. 50% of the GroP-WTA-repeating units are modified with glucose (Fig. 3a). In contrast, none of the WTA samples of any of the tagE, gtaB, or pgcA mutants was found to contain glucose. High-performance liquid chromatography coupled to a mass spectrometry detector (HPLC-MS) and nuclear magnetic resonance (NMR) spectroscopy confirmed the presence of glucose-substituted GroP-repeating units in the WT and the absence of glucose in the mutants (Fig. 3b and c; Fig. S2). These findings reflect earlier reports on the presence of glucose on S. epidermidis GroP-WTA (9), and they confirm that the PgcA-GtaB-TagE pathway is required for GroP-WTA glycosylation with glucose. NMR analysis indicated that the glucose units are α-configured at the anomeric center and attached to the C2-position of GroP. About 15% of the glucose residues are modified with D-alanine at the O6-position of glucose [Fig. 3c; supplemental material (NMR extended description); Table S3; Fig. S7]. The α-configuration is reminiscent of the configuration of GlcNAc on RboP-WTA introduced by the TagE-related TarM in S. aureus (28).

Fig 3.

Fig 3

WTA analysis of the S. epidermidis mutants ∆tagE, ∆pgcA, ∆gtaB, and of ∆tagE containing the pRB473 plasmid carrying tagE, pgcA, and gtaB genes for complementation. (a) Ratio of glucose per phosphate content of WTA was measured enzymatically. (b) HPLC-MS: Extracted ion chromatograms of GroP-Gro [(M - H)- = 245.0432] and GroP-GroP [(M - H)- = 325.0095] with [GroP-Gro-Glc; (M - H)- = 407.096] [GroP-GroP-Glc; (M - H)- = 487.0623] or without glucose substitution. (c) 1H NMR spectra reveal D-glucose on WTA of the S. epidermidis 1457 WT (at the C2-position of GroP), while the deletion of tagE results in the absence of glucose on WTA. For (a), data represent the mean ± SEM of at least three independent experiments. Ordinary one-way ANOVA was used to determine statistical significance, followed by Tukey’s multiple comparisons tests, indicated as: not significant (ns), **P < 0.01, and ***P < 0.001.

The absence of glucose on GroP-WTA in the ∆tagE mutant did not alter biofilm formation by S. epidermidis 1457 (Fig. S3). Moreover, no differences in growth kinetics (Fig. S1), cell wall thickness, or cell shape (Fig. S4) were observed in the mutants, indicating that the absence of glucose on GroP-WTA has no major impact on the overall cellular properties of the S. epidermidis surface.

Preincubation of ΦE72 with purified cell wall effectively prevented ΦE72 infection of S. epidermidis only if glucose was present on the attached WTA (Fig. 6a). In contrast, purified WTA had no such effects (Fig. S5), suggesting that ΦE72 only binds to its GroP WTA receptor when it is modified with glucose and embedded in the cell wall matrix.

UDP-glucose generated by PgcA and GtaB is also required for the biosynthesis of the glycolipid diglucosyldiacylglycerol (DGlcDAG), which serves as anchor structure for lipoteichoic acid (LTA) polymers in B. subtilis and many other Firmicutes (Fig. 4a) (3436). However, DGlcDAG is not essential for LTA biosynthesis because mutants lacking glycolipids still produce LTA attached to phosphatidylglycerol lipids (36, 37). The S. epidermidis pgcA and gtaB mutants, but not the tagE mutant, also lacked DGlcDAG, which was present in the parental strain (Fig. 4b), indicating that DGlcDAG is synthesized in S. epidermidis by the same pathway as in B. subtilis and S. aureus.

Fig 4.

Fig 4

Glycolipid detection by thin layer chromatography (TLC). (a) LTA glycolipid biosynthesis pathway as described for S. aureus and B. subtilis [adapted from reference (37)]. (b) Glycolipid detection on a TLC plate stained with α-naphthol/sulfuric acid. For positive control, 5 µg of digalactosyldiacylglycerol (DGDG) was used, while the solvent methanol/chloroform (1:1) was used as negative control (n.cont.). One representative experiment of three independent experiments is shown.

Lack of WTA glucose impairs the binding of known S. epidermidis siphoviruses but promotes the binding of podoviruses

Several other phages in addition to ΦE72 were analyzed for the impact of GroP-WTA glucose modification on phage binding and infection. The ΦE72-related siphoviruses Φ456,Φ459, and Φ27, which are known to bind to S. epidermidis 1457 (23), showed reduced binding to the pgcA, gtaB, and tagE mutants compared to the WT, but the reduction was less pronounced as for ΦE72 (Fig. 5a and f). Φ459 was equally reduced in its capacities to propagate in the mutants as ΦE72 (Fig. 5b). Despite their capacity to bind S. epidermidis 1457, Φ27 and Φ456 did not form clear plaques on WT or mutant strains. Two recently isolated myoviruses of the genus sepunavirus, ΦBE04 and ΦBE06 (38), showed no reduction in their ability to bind and infect the mutants, suggesting that these myoviruses are not dependent on glucose-modified GroP-WTA (Fig. 5d and e). This resembles the infection behavior of myovirus ΦK, for which the WTA backbone is sufficient for binding to S. aureus (13).

Fig 5.

Fig 5

TagE-glycosylated WTA increases the binding of siphoviruses but reduces podovirus binding. WTA glycosylation-deficient mutants of S. epidermidis show decreased binding of ΦE72-related siphoviruses Φ459, Φ456, and Φ27 (a) but increased binding of the podoviruses ΦUKE3, ΦSpree, and ΦBE03 (c), while the GroP-GalNAc-specific siphovirus Φ187 still shows strong binding (a). WTA glycosylation-deficient mutants of S. epidermidis show less plaque formation by ΦE72-related siphovirus Φ459 (b), while plaque formation by the myoviruses ΦBE04 (d) and ΦBE06 (e) remains unchanged. (f) Lysis zones by siphoviruses decrease in the absence of tagE but increase for podoviruses. Myoviruses show the formation of lysis zones independent of the presence or absence of tagE [pRB = pRB473 (empty vector control); comp = complementation with tagE, gtaB, and pgcA genes]. The data represent the mean ± SEM of at least three independent experiments. Ordinary one-way ANOVA was used to determine statistical significance vs S. epidermidis 1457 WT, followed by Dunnett’s multiple comparisons tests, indicated as: not significant (ns), *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. P-values are shown if appropriate.

Several other phages, which bind S. epidermidis 1457 but cannot replicate in this strain, behaved differently. Siphovirus Φ187, which is only distantly related to ΦE72 and requires GroP-WTA modified with GalNAc for infection of target cells (25), still bound to the GroP-WTA glucose-deficient mutants (Fig. 5a), indicating that the GroP-WTA glucose modifications are not necessary for Φ187 binding. Φ187 even showed higher plasmid transduction efficiency in the absence of GroP-WTA glucose residues (Fig. 6c). Furthermore, the podoviruses ΦUKE3, ΦSpree, and ΦBE03 (38) exhibited strongly increased binding to the pgcA, gtaB, and tagE mutants compared to the WT (Fig. 5c and f), indicating that these phages are attenuated for binding in the presence of glucose residues on GroP-WTA. Thus, the GroP-WTA glucose residues are important for most of the known S. epidermidis phages, albeit in quite different ways, depending on the individual phage.

Fig 6.

Fig 6

TagE-modified WTA determines horizontal gene transfer between CoNS. (a) The purified cell wall of S. epidermidis 1457 with glucose-modified GroP-WTA (black) prevents plaque formation by ΦE72 more efficiently than in the absence of glucose (gold). (b) Transduction of the plasmid pRB473 by ΦE72 is decreased if the receiving strain lacks WTA modification with glucose. (c) Transduction of pRB473 with Φ187 is increased in the absence of glucose on GroP-WTA. (d) ΦE72 binds to different strains of S. epidermidis, but binding is prevented by RboP expression encoded by the tarIJLM2 cluster. (e) ΦE72-mediated transduction of pBASE6 or pC183-S3-GFP to CoNS depends on high TagE homology. Strain names are given in brackets. The data represent the mean ± SEM of at least three independent experiments. For (a), two-way ANOVA was used to determine statistical significance comparing unsupplemented control vs WT cell wall supplementation (black) and supplementation of WT cell wall vs ΔtagE cell wall (gold), followed by Tukey’s multiple comparisons tests. For (b) and (c), unpaired t tests were used to determine statistical significance vs S. epidermidis 1457 WT, and for (d), ordinary one-way ANOVA was used to determine statistical significance vs S. epidermidis 1457 WT, followed by Tukey’s multiple comparisons tests. Statistical significance is indicated as: not significant (ns), *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

The presence of tagE in the genomes of CoNS species corresponds to the capacity of ΦE72 to transduce these species

The tagE gene was found in all available S. epidermidis genomes (218), 212 of which encoded a full-length DNA sequence with more than 96% nucleotide identity, suggesting that the substitution of GroP-WTA with glucose is a general trait in S. epidermidis. Accordingly, ΦE72 bound well to the tested S. epidermidis strains from at least two different sequence types (ST86 and ST32) with one exception (Fig. 6d). Notably, ΦE72 did not bind to S. epidermidis E73 (ST23), which produces RboP-WTA in addition to GroP-WTA (6). However, an E73 tarIJLM2 mutant lacking RboP-WTA was effectively bound by ΦE72, indicating that the additional RboP-WTA shields the surface of S. epidermidis in a way that precludes binding of the phage. This effect was confirmed by the expression of the RboP-WTA encoding gene cluster of strain E73 in the GroP-WTA expressing strain 1457, which resulted in reduced phage binding (Fig. 6d).

GroP-WTA has been reported in several other CoNS species. The nature of the sugar modifications in these species has remained largely unknown, but several CoNS have been reported to contain either glucose, GlcNAc, or GalNAc attached to WTA (9). We succeeded in transducing many different CoNS species via ΦE72 with either the staphylococcal shuttle vector pBASE or the green-fluorescent protein-expressing plasmid pC183-S3 GFP. Some of the available CoNS genomes were found to encode TagE homologs, albeit with different degrees of sequence conservation, ranging from 44% to 83% similarity (Table 1). Those species with TagE similarities above 69% could be transduced by ΦE72, while those with less conserved TagE homologs did not take up DNA from ΦE72 (Fig. 6e), suggesting that only CoNS with highly conserved versions of TagE may glycosylate their GroP-WTA in a similar way as in S. epidermidis, while the others may glycosylate either other WTA backbone types or may transfer other sugars. Among the tested species, Staphylococcus pasteuri, Staphylococcus lugdunensis, Staphylococcus cohnii, Staphylococcus caprae, Staphylococcus schleiferi, Staphylococcus carnosus, Staphylococcus simulans, and Staphylococcus warneri strains were transducible with ΦE72. Isolates of two of these species, S. cohnii and S. warneri, have indeed previously been described to produce GroP-WTA, which is modified with glucose (9). In contrast to the varying degrees of conservation of tagE, the pgcA and gtaB genes are present in virtually all Staphylococcus genomes with high sequence similarity, including S. aureus, probably because UDP-glucose is required in all these species for DGlcDAG glycolipid synthesis (37). Among the strains that encode highly conserved TagE homologs, tagE was encoded in the vicinity of both pgcA and gtaB only in S. pasteuri and S. lugdunensis, in addition to S. epidermidis (Table 1). Thus, phage ΦE72 represents a helpful tool for studying WTA properties and an attractive vehicle for interspecies transduction of DNA among members of the genus Staphylococcus.

TABLE 1.

Conservation of TagE homologs in CoNS strains used for transduction, ordered according to amino acid sequence similarity

Species Strain name Query cover (%) Sequence identity (%) Sequence similarity (%) tagE, pgcA, and gtaB encoded together
S. epidermidis TÜ3298 100 99 99 Yes
S. pasteuri ATCC51129 100 69 83 Yes
S. lugdunensis HKU09-01 99 64 81 Yes
S. cohnii ATCC29974 99 61 79 No
S. caprae BK14568/12 99 52 73 No
S. schleiferi ATCC43808 98 50 69 No
S. carnosus TM300 99 48 69 No
S. simulans ATCC27848 99 46 69 No
S. warneri BK15472/12 99 48 69 No
Staphylococcus haemolyticus 51–14 99 45 65 No
Staphylococcus pseudintermedius ED99 100 43 64 No
Staphylococcus hominis ATCC27844 65 28 54 No
Staphylococcus saprophyticus BK5803/14 85 25 44 No

DISCUSSION

WTA structures are known to be highly diverse among Firmicutes, often with species- or even clone-specific composition (7, 39). Most S. epidermidis produce a WTA type that is entirely different from that of S. aureus with a GroP rather than an RboP backbone. This study shows that S. epidermidis uses a GroP backbone with unmodified or with alanylated glucose. It remains unclear why S. epidermidis and S. aureus have developed such entirely different WTA types. The different structures may limit the number of bacteriophages that can infect and harm either one or both species. However, ΦK, one the most lytic bacteriophages, can lyse Staphylococcus cells irrespective of the WTA backbone structure, and a recent study has demonstrated that several Staphylococcus myoviruses can infect both, S. aureus and S. epidermidis (40). The differences in WTA may limit infections and concomitant lysogenization or transduction events by specific members of the siphovirus group, which depend much more on a specific WTA backbone and glycosylation type than myoviruses. Notably, the presence of glucose on GroP-WTA prevented adsorption to S. epidermidis by all tested podoviruses (ΦUKE3, ΦSpree, and ΦBE03). The number of available S. epidermidis-targeting phages is still very limited, which impedes more extensive studies on the susceptibility of S. epidermidis WT and WTA mutant strains for different phage types. Discovery programs for the identification of new phages that can infect S. epidermidis will help to clarify these questions in the future.

WTA is an important bacterial ligand for host receptors on mammalian immune cells with critical roles in innate immunity (8, 41). WTA glycosylated with GlcNAc can activate the scavenger receptor langerin on skin Langerhans cells (42). S. aureus is found on the skin of atopic dermatitis patients eliciting skin inflammation in a process that probably involves WTA-langerin interaction (8). In contrast, S. epidermidis cannot activate langerin (42), probably because its GroP-WTA is glycosylated with glucose. It may be advantageous for S. epidermidis, one of the most abundant skin-colonizers (1), and for other CoNS to avoid skin inflammation by producing a non-inflammatory WTA type decorated with glucose.

S. epidermidis uses the same pathway for GroP-WTA glycosylation with glucose residues as described for B. subtilis (29). Activation of glucose via the PgcA and GtaB enzymes yields UDP-glucose as a donor of glucose residues, which are subsequently transferred to the WTA backbone by TagE. Other WTA glycosyltransferases apart from TarM (28), including those transferring glucose to RboP-WTA in B. subtilis W23 (TarQ) (7, 11), GlcNAc to RboP-WTA in certain S. aureus clones (TarS and TarP) (11, 43), or GalNAc to GroP-WTA in S. aureus ST395 (TagN) (25), share no or very low similarity with TagE. However, protein structure prediction with Alphafold 2 revealed that TagE most likely forms a symmetric, propeller-like homotrimer with each monomer divided into the characteristic glycosyltransferase domain and the β-sheets containing trimerization domain as previously described for the well-studied S. aureus glycosyltransferase TarM (Fig. S6) (4446).

In addition to glucose, WTA is usually also modified with D-alanine (39). Since GroP-repeating units have only one free hydroxyl group for substitution with either D-alanine or glucose, it is not surprising that only ca. 50% of the repeating units carried glucose residues. The teichoic acid D-alanylation machinery attaches D-alanine to a variety of different molecules including LTA, RboP-WTA, and GroP-WTA (47). Its limited specificity for acceptor substrates may explain why a minor portion of the glucose residues on S. epidermidis GroP-WTA is also alanylated. GroP-repeating units are shorter than RboP-repeating units, which may explain why the additional RboP-WTA polymers of S. epidermidis E73 are probably longer and preclude binding of ΦE72 to strain E73. The additional WTA may, therefore, represent a further strategy to interfere with phage infection and with the interaction of other WTA-binding molecules.

Several other CoNS species might produce a similar WTA type as S. epidermidis because they encode potential TagE proteins and interact with ΦE72 as shown by successful ΦE72-dependent transduction (Fig. 6e). This is supported by data from Endl et al. (9), showing that S. warneri and S. cohnii, both of which are transducible with ΦE72, express GroP-WTA with glucose modification. Likewise, S. haemolyticus and S. hominis, which could not be transduced, have been found not to produce glucose-modified GroP-WTA in the previous study (9). Interspecies horizontal gene transfer via WTA-binding transducing phages appears to be rather common among CoNS and may have contributed to the import of the methicillin-resistance conferring mecA gene into S. epidermidis and, eventually, to S. aureus to create MRSE and MRSA clones (20). It remains mysterious how the barrier for horizontal gene transfer between S. epidermidis and S. aureus that results from the substantial differences in WTA structure could be overcome. Specific S. epidermidis clonal lineages with both, GroP-WTA and S. aureus-type RboP-WTA such as ST10, ST23, and ST87 (6) or the S. aureus lineage ST395 producing CoNS-type GroP-WTA (14), may represent critical hubs for the exchange of genetic material between the species S. epidermidis and S. aureus. Several CoNS species encode potential WTA glycosyltransferase homologs with only low or no similarity to TagE. They may produce other WTA backbones or glycosylate their WTA with other sugars.

S. epidermidis often causes difficult-to-treat biofilm-based infections on implanted materials, which frequently require surgical replacement (4). Treatment with lytic bacteriophages that could destroy S. epidermidis biofilms holds promise for the development of new therapeutic strategies (3, 18). Understanding how phages detect suitable host bacteria and which S. epidermidis clones express corresponding phage-binding WTA motives will be important for the success of such strategies. The TagE-mediated WTA glycosylation with glucose might contribute to the narrow host range of lytic podoviruses such as ΦBE03 (38). Accordingly, finding podoviruses, which bind to GroP-WTA glucose might help to develop efficient therapeutic phage cocktails. Moreover, glycosylated WTA is a major antigen for protective antibodies against S. aureus (43, 48, 49) and, probably, also S. epidermidis. Therefore, it represents a particularly attractive antigen for vaccine development (49). As for phage therapy, the success of such vaccination strategies will depend on in-depth knowledge on the structure and prevalence of WTA glycoepitopes among different S. epidermidis lineages. Our study may motivate more extensive investigations on WTA glycoepitopes in different staphylococcal pathogens and commensals.

MATERIALS AND METHODS

Bacterial strains and growth conditions

S. epidermidis and S. aureus strains were cultivated in a basic medium (BM) and incubated at 37°C on an orbital shaker. Escherichia coli strains were cultivated in lysogeny broth (LB). Media were supplemented with appropriate antibiotics chloramphenicol (10 µg/mL) or ampicillin (100 µg/mL). E. coli DC10b and S. aureus PS187 ∆sauUSIhsdR were used as cloning hosts, and S. epidermidis 1457 was used for gene deletion studies. Bacteriophages and propagation strains used in this study are listed in Table S1.

Transposon mutagenesis of S. epidermidis strain 1457

The transposon plasmid pBTn described previously (26) was used to create a transposon library in S. epidermidis 1457. The features of this temperature-sensitive E. coli/S. aureus shuttle vector include a mini-transposon with an erythromycin resistance cassette flanked by inverted repeats from the horn fly transposon and a xylose-inducible transposase Himar1, which can mobilize the mini-transposon and integrate it into the chromosome with no bias for any specific sequence. Transposon library construction has been described in detail before (28). In short, S. epidermidis 1457 was transformed with pBTn followed by mobilization of the mini-transposon into the genome upon xylose induction of the transposase. The pBTn plasmid was cured via shifts to nonpermissive temperature.

Isolation of phage-resistant transposon mutants

To isolate phage-resistant mutants, the transposon mutant library was infected with ΦE72 at a multiplicity of infection (MOI) of at least 100. After incubation for up to 4 h, the cells were centrifuged at 5,000 × g for 10 min and plated on tryptic soy agar (TSA) containing erythromycin. Single colonies of surviving mutants were transferred to fresh TSA agar plates repeatedly. Phage resistance was confirmed by spot assays with ΦE72, and the phage-resistant mutants were treated with 1 µg/mL mitomycin to test for and to exclude lysogeny. To identify the site of transposon insertion, total DNA was isolated, purified with the NucleoSpin tissue kit (Macherey-Nagel, Düren), digested, religated, multiplied with primers erm-For and erm-Rev (Table S2), which anneal to the erythromycin resistance cassette of the mini-transposon, and sequenced.

Molecular genetic methods

For the construction of the tagE, pgcA, and gtaB mutants in S. epidermidis 1457, the pBASE6 E. coli/S.aureus shuttle vector was used according to standard procedures (50). For mutant complementation, plasmid pRB473 was used (51). The primers for knockout and complementation plasmid construction are listed in (Table S2). Both pBASE6 and pRB473 containing either the respective up- and downstream fragments for knockout construction (pBASE6) or the complementation sequence (pRB473) were used to transform E. coli DC10b and subsequently PS187 ∆sauUSIhsdR by electroporation. The plasmids were subsequently transferred to S. epidermidis strain 1457 by transduction with Φ187 using S. aureus PS187 ∆sauUSIhsdR as donor strain as described previously (19).

Phage binding, infection, and transduction assays

Phage spot assays were performed as described previously (14). All applied bacteriophages (Table S1) were propagated in suitable bacterial host strains, and phage lysates were filtered to yield sterile phage suspensions. Test bacteria were cultivated overnight in fresh BM. OD600 = 0.1 was adjusted in 5 mL LB soft agar for the preparation of bacterial overlay lawns. Five or 10 µL of phage suspensions were spotted onto the bacterial lawns. After overnight incubation at 37°C for podoviruses and siphoviruses, and 30°C for myoviruses, phage-clearing zones and individual plaques were observed and recorded. Efficiency of plating (EOP) was calculated by dividing the number of plaques formed on the deletion mutants and complemented strains by the number of plaques formed on the S. epidermidis 1457 WT. The WT was set to 100% EOP. Plaque formation was inhibited by incubating phage suspensions with different amounts of purified cell wall or WTA for 15 minutes, prior to spotting on the indicator strain.

Phage adsorption efficiency was determined as described previously with minor modifications (14). Briefly, adsorption rates were analyzed by mixing approximately 106 plaque forming units per mL (PFU/mL) in BM supplemented with 4 mM CaCl2 with the tested bacteria at an OD600 of 0.5 and incubating for 15 min at 37°C. The samples were subsequently centrifuged, and the supernatants were spotted on indicator strains to determine the number of unbound phages in the supernatant. The adsorption rate was calculated by dividing the number of bound phages by the number of input phages.

Transduction experiments were performed as described previously (14). Briefly, 1 mL of exponentially growing cultures of a recipient strain was adjusted to an OD600 of 0.5. The cells were sedimented by centrifugation and resuspended in 200 µL of phage buffer containing 0.1% gelatin, 1 mM MgSO4, 4 mM CaCl2, 50 mM Tris, and 0.1 M NaCl. A mixture was prepared by combining 200 µL of bacteria in phage buffer with 100 µL of lysates obtained from S. aureus PS187 and S. epidermidis 1457 donor strains carrying plasmids of choice. Samples were then incubated for 15 min at 37°C, diluted, and plated on chloramphenicol-containing BM agar to count colonies. When S. epidermidis 1457 was transduced, sodium citrate was added to a final concentration of 15 mM after the incubation step, and selection plates were supplemented with 20 mM sodium citrate.

Electron microscopy

S. epidermidis 1457 WT, ∆tagE, ∆pgcA, and ∆gtaB were grown until stationary phase and fixed at an OD600 of 10 in 200 µL Karnovsky’s fixative (3% formaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer pH 7.4) for 24 h. Samples were then centrifuged at 1,400 × g for 5 min, supernatant was discarded, and pellets were resuspended in approximately 20 µL agarose (3.9%) at 37°C, cooled to room temperature, and cut into small pieces. Postfixation was based on 1.0% osmium tetroxide containing 2.5% potassium ferrocyanide (Morphisto) for 2 h. After following the standard methods, samples were embedded in glycide ether and cut using an ultramicrotome (Ultracut E, Reichert). Ultra-thin sections (30 nm) were mounted on copper grids and analyzed using a Zeiss LIBRA 120 transmission electron microscope (Carl Zeiss) operating at 120 kV.

Cell wall and WTA isolation

WTA was isolated as described previously (14, 52, 53) with minor modifications. Briefly, bacterial cells from 2 L of overnight cultures were washed and disrupted with glass beads in a cell disrupter (Euler). Cell lysates were incubated at 37°C overnight in the presence of DNase and RNase. SDS was added to a final concentration of 2% followed by ultrasonication for 15  min. Cell walls were washed several times to remove SDS. Purified cell wall was used for further experiments. To release WTA from cell walls, samples were treated with 5% trichloroacetic acid for 4 h at 65°C. Peptidoglycan debris was separated via centrifugation (10 min, 14,500 × g). Determination of phosphate amounts as described previously (53, 54) was used for WTA quantification. Crude WTA extracts were further purified as already described (28). Briefly, the pH of the crude extract was adjusted to five with NaOH and dialyzed against the water with a Slide-A-Lyzer Dialysis Cassette (molecular weight cut-off (MWCO) of 3.5  kDa; Thermo Fisher Scientific). The dialyzed WTA was further lyophilized. For HPLC-MS analysis, 50 µL of 100 mM WTA sample was hydrolyzed with 100 mM NaOH at 60°C for 2 h. For NMR, 10–15 mg lyophilized WTA sample was used. WTA was stored at −20°C. Detailed explanations of the HPLC-MS and NMR methods can be found in the supplemental material’s extended descriptions of detailed methods.

Enzymatic determination of glucose in the WTA samples

The High Sensitivity Glucose Assay Kit (mak181, Sigma-Aldrich) was used to determine the glucose content in the WTA sample. In a vacuum concentrator at 60°C, 50 µL of dialyzed WTA samples and 50 µL of 1 mM glucose standard solution were dried. The samples and the standard solution each had 100 µL of 0.5 M HCl added to them and then cooked for 2 h in a water bath. The glucose standard was diluted 1:50 resulting in a 10 µM concentration, and different volumes were used to cover a range of 0–100 pmol. Samples were also diluted at least 1:50, and different dilutions of the samples were tested in a 96-well plate. The assay was performed according to the manufacturer’s instructions. The fluorescence intensity was measured at excitation wavelength 535 nm and emission wavelength 587 nm.

Phage saturation with purified cell wall or WTA

Purified cell wall and WTA concentrations were measured by weighing the cell wall or determination of the phosphate content. 100 µL of approximately 105 PFU/mL ΦE72 for WTA supplementation experiments and 100 µL of approximately 106 PFU/mL ΦE72 for cell wall supplementation experiments were mixed with different concentrations of WTA or cell wall and incubated at 37°C for 15 min while shaking at 300 rpm. Inhibition of plaque formation was measured by spotting the solution on soft agar containing S. epidermidis 1457 as indicator strain.

Glycolipid isolation, TLC, and detection with α-naphthol

The detection of glycolipids was performed similar to a previously described method (37). S. epidermidis 1457 and the respective mutants were grown to OD600 of 3.5. 5 mL of bacterial suspension were washed and resuspended in 500 µL of 100 mM sodiumacetate (pH 4.7) and transferred into glass vials. 500 µL chloroform and 500 mL methanol were added, and the mixture was vortexed vigorously. The samples were centrifuged at 4,600 × g for 20 min at 4°C, and the lower phase was dried overnight and resuspended in 25 µL methanol and chloroform in a 1:1 ratio. The whole sample was applied to a high-performance thin-layer chromatography (HPTLC) silica gel 60 plate (10 × 10 cm; Merck) with a Hamilton syringe. A positive control containing 5 µg digalactosyldiacylglycerol (DGDG, Sigma-Aldrich) was used. A Linomat 5 (Camag) and an auto-developing chamber (Camag) were used to apply the sample to the TLC plate and to run it with a solvent containing 65:25:4 (vol/vol/vol) chloroform/methanol/H2O. The dried TLC plate was sprayed with 3.2% α-naphthol in methanol/H2SO4/H2O 25:3:2 (vol/vol/vol), and the glycolipids were visualized by heating the plate at 110°C for a few minutes.

In silico analysis

All statistical analyses were performed with Graph Pad Prism 9.2.0 (GraphPad Software, La Jolla, USA). Multiple sequence alignment was performed with SnapGene 5.3.2 using MUSCLE. Protein structure prediction was done using AlphaFold2 with ColabFold (45, 46).

ACKNOWLEDGMENTS

We thank David Gerlach, Xin Du, and Bernhard Krismer for helpful discussions, Arnaud Kengmo Tchoupa and Ulrike Redel for help with TLC, and Y. Que and E. Baumgartner for supply of phages.

This work was financed by grants from the German Research Foundation to A.P. (TRR34; TRR156 project ID 246807620; PE 805/7–1 project ID 410190180; PE 805/8–1 project ID 410190180) and the German Center for Infection Research (DZIF) to A.P. The authors acknowledge infrastructural support by the Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections" project ID 39083813.

Contributor Information

Andreas Peschel, Email: andreas.peschel@uni-tuebingen.de.

Tarek Msadek, Institut Pasteur, Paris, France.

Michael Otto, National Institute of Allergy and Infectious Diseases Division of Intramural Research, Bethesda, USA.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/mbio.01990-23.

Fig. S1. mbio.01990-23-s0001.tif.

ΦE72 prevents growth of S. epidermidis 1457 wild type.

mbio.01990-23-s0001.tif (531.8KB, tif)
DOI: 10.1128/mbio.01990-23.SuF1
Fig S2. mbio.01990-23-s0002.tif.

Area-under-the-curve quantification of GroP-GroP-Glc.

mbio.01990-23-s0002.tif (485.9KB, tif)
DOI: 10.1128/mbio.01990-23.SuF2
Fig S3. mbio.01990-23-s0003.tif.

Biofilm formation.

mbio.01990-23-s0003.tif (509.9KB, tif)
DOI: 10.1128/mbio.01990-23.SuF3
Fig S4. mbio.01990-23-s0004.tif.

Electron microscopy.

DOI: 10.1128/mbio.01990-23.SuF4
Fig. S5. mbio.01990-23-s0005.tif.

Saturation of ΦE72 with purified WTA.

mbio.01990-23-s0005.tif (371.5KB, tif)
DOI: 10.1128/mbio.01990-23.SuF5
Fig. S6. mbio.01990-23-s0006.tif.

Structural prediction of the S. epidermidis TagE trimer with Alphafold2.

DOI: 10.1128/mbio.01990-23.SuF6
Fig. S7. mbio.01990-23-s0007.tif.

NMR spectra recorded for WTA isolated from S. epidermidis wild type.

DOI: 10.1128/mbio.01990-23.SuF7
Tables S1 to S4. mbio.01990-23-s0008.docx.

Bacteriophages, primers, NMR chemical shifts, and tagE conservation in S. epidermidis.

mbio.01990-23-s0008.docx (49.2KB, docx)
DOI: 10.1128/mbio.01990-23.SuF8
Supplemental material. mbio.01990-23-s0009.docx.

Legends for supplemental figures and extended descriptions of detailed methods.

DOI: 10.1128/mbio.01990-23.SuF9

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Severn MM, Horswill AR. 2023. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol 21:97–111. doi: 10.1038/s41579-022-00780-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Otto M. 2009. Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol 7:555–567. doi: 10.1038/nrmicro2182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Schilcher K, Horswill AR. 2020. Staphylococcal biofilm development: structure, regulation, and treatment strategies. Microbiol Mol Biol Rev 84:e00026-19. doi: 10.1128/MMBR.00026-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Becker K, Heilmann C, Peters G. 2014. Coagulase-negative staphylococci. Clin Microbiol Rev 27:870–926. doi: 10.1128/CMR.00109-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Otto M. 2018. Staphylococcal biofilms. Microbiol Spectr 6. doi: 10.1128/microbiolspec.GPP3-0023-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Du X, Larsen J, Li M, Walter A, Slavetinsky C, Both A, Sanchez Carballo PM, Stegger M, Lehmann E, Liu Y, Liu J, Slavetinsky J, Duda KA, Krismer B, Heilbronner S, Weidenmaier C, Mayer C, Rohde H, Winstel V, Peschel A. 2021. Staphylococcus epidermidis clones express Staphylococcus aureus-type wall teichoic acid to shift from a commensal to pathogen lifestyle. Nat Microbiol 6:757–768. doi: 10.1038/s41564-021-00913-z [DOI] [PubMed] [Google Scholar]
  • 7. Brown S, Santa Maria JP, Walker S. 2013. Wall teichoic acids of Gram-positive bacteria. Annu Rev Microbiol 67:313–336. doi: 10.1146/annurev-micro-092412-155620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. van Dalen R, Peschel A, van Sorge NM. 2020. Wall teichoic acid in Staphylococcus aureus host interaction. Trends Microbiol 28:985–998. doi: 10.1016/j.tim.2020.05.017 [DOI] [PubMed] [Google Scholar]
  • 9. Endl J, Seidl HP, Fiedler F, Schleifer KH. 1983. Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch Microbiol 135:215–223. doi: 10.1007/BF00414483 [DOI] [PubMed] [Google Scholar]
  • 10. Ingmer H, Gerlach D, Wolz C. 2019. Temperate phages of Staphylococcus aureus. Microbiol Spectr 7. doi: 10.1128/microbiolspec.GPP3-0058-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Brown S, Xia G, Luhachack LG, Campbell J, Meredith TC, Chen C, Winstel V, Gekeler C, Irazoqui JE, Peschel A, Walker S. 2012. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 109:18909–18914. doi: 10.1073/pnas.1209126109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Gerlach D, Sieber RN, Larsen J, Krusche J, De Castro C, Baumann J, Molinaro A, Peschel A. 2022. Horizontal transfer and phylogenetic distribution of the immune evasion factor tarP. Front Microbiol 13:951333. doi: 10.3389/fmicb.2022.951333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Li X, Gerlach D, Du X, Larsen J, Stegger M, Kühner P, Peschel A, Xia G, Winstel V. 2015. An accessory wall teichoic acid glycosyltransferase protects Staphylococcus aureus from the lytic activity of podoviridae. Sci Rep 5:17219. doi: 10.1038/srep17219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Winstel V, Liang C, Sanchez-Carballo P, Steglich M, Munar M, Bröker BM, Penadés JR, Nübel U, Holst O, Dandekar T, Peschel A, Xia G. 2013. Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nat Commun 4:2345. doi: 10.1038/ncomms3345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Xia G, Corrigan RM, Winstel V, Goerke C, Gründling A, Peschel A. 2011. Wall teichoic acid-dependent adsorption of staphylococcal siphovirus and myovirus. J Bacteriol 193:4006–4009. doi: 10.1128/JB.01412-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. O’Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71:1836–1842. doi: 10.1128/AEM.71.4.1836-1842.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Cerca N, Oliveira R, Azeredo J. 2007. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol 45:313–317. doi: 10.1111/j.1472-765X.2007.02190.x [DOI] [PubMed] [Google Scholar]
  • 18. Kilcher S, Loessner MJ. 2019. Engineering bacteriophages as versatile biologics. Trends Microbiol 27:355–367. doi: 10.1016/j.tim.2018.09.006 [DOI] [PubMed] [Google Scholar]
  • 19. Winstel V, Kühner P, Rohde H, Peschel A. 2016. Genetic engineering of untransformable coagulase-negative staphylococcal pathogens. Nat Protoc 11:949–959. doi: 10.1038/nprot.2016.058 [DOI] [PubMed] [Google Scholar]
  • 20. Rolo J, Worning P, Nielsen JB, Bowden R, Bouchami O, Damborg P, Guardabassi L, Perreten V, Tomasz A, Westh H, de Lencastre H, Miragaia M. 2017. Evolutionary origin of the staphylococcal cassette chromosome mec (SCCmec). Antimicrob Agents Chemother 61:e02302-16. doi: 10.1128/AAC.02302-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. 2018. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033. doi: 10.1038/nrdp.2018.33 [DOI] [PubMed] [Google Scholar]
  • 22. Mack D, Siemssen N, Laufs R. 1992. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun 60:2048–2057. doi: 10.1128/iai.60.5.2048-2057.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Fišarová L, Botka T, Du X, Mašlaňová I, Bárdy P, Pantůček R, Benešík M, Roudnický P, Winstel V, Larsen J, Rosenstein R, Peschel A, Doškař J. 2021. Staphylococcus epidermidis phages transduce antimicrobial resistance plasmids and mobilize chromosomal islands. mSphere 6:e00223-21. doi: 10.1128/mSphere.00223-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Fanaei Pirlar R, Wagemans J, Ponce Benavente L, Lavigne R, Trampuz A, Gonzalez Moreno M. 2022. Novel bacteriophage specific against Staphylococcus epidermidis and with antibiofilm activity. Viruses 14:1340. doi: 10.3390/v14061340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Winstel V, Sanchez-Carballo P, Holst O, Xia G, Peschel A. 2014. Biosynthesis of the unique wall teichoic acid of Staphylococcus aureus lineage ST395. mBio 5:e00869. doi: 10.1128/mBio.00869-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Li M, Rigby K, Lai Y, Nair V, Peschel A, Schittek B, Otto M. 2009. Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob Agents Chemother 53:4200–4210. doi: 10.1128/AAC.00428-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Allison SE, D’Elia MA, Arar S, Monteiro MA, Brown ED. 2011. Studies of the genetics, function, and kinetic mechanism of TagE, the wall teichoic acid glycosyltransferase in Bacillus subtilis 168. J Biol Chem 286:23708–23716. doi: 10.1074/jbc.M111.241265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Xia G, Maier L, Sanchez-Carballo P, Li M, Otto M, Holst O, Peschel A. 2010. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem 285:13405–13415. doi: 10.1074/jbc.M109.096172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Lazarevic V, Soldo B, Médico N, Pooley H, Bron S, Karamata D. 2005. Bacillus subtilis alpha-phosphoglucomutase is required for normal cell morphology and biofilm formation. Appl Environ Microbiol 71:39–45. doi: 10.1128/AEM.71.1.39-45.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Pooley HM, Paschoud D, Karamata D. 1987. The gtaB marker in Bacillus subtilis 168 is associated with a deficiency in UDPglucose pyrophosphorylase. J Gen Microbiol 133:3481–3493. doi: 10.1099/00221287-133-12-3481 [DOI] [PubMed] [Google Scholar]
  • 31. Yasbin RE, Maino VC, Young FE. 1976. Bacteriophage resistance in Bacillus subtilis 168, W23, and interstrain transformants. J Bacteriol 125:1120–1126. doi: 10.1128/jb.125.3.1120-1126.1976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Qian Z, Yin Y, Zhang Y, Lu L, Li Y, Jiang Y. 2006. Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication. BMC Genomics 7:74. doi: 10.1186/1471-2164-7-74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Swoboda JG, Campbell J, Meredith TC, Walker S. 2010. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 11:35–45. doi: 10.1002/cbic.200900557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Jorasch P, Wolter FP, Zähringer U, Heinz E. 1998. A UDP glucosyltransferase from Bacillus subtilis successively transfers up to four glucose residues to 1,2-diacylglycerol: expression of ypfP in Escherichia coli and structural analysis of its reaction products. Mol Microbiol 29:419–430. doi: 10.1046/j.1365-2958.1998.00930.x [DOI] [PubMed] [Google Scholar]
  • 35. Kiriukhin MY, Debabov DV, Shinabarger DL, Neuhaus FC. 2001. Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. J Bacteriol 183:3506–3514. doi: 10.1128/JB.183.11.3506-3514.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Fedtke I, Mader D, Kohler T, Moll H, Nicholson G, Biswas R, Henseler K, Götz F, Zähringer U, Peschel A. 2007. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol 65:1078–1091. doi: 10.1111/j.1365-2958.2007.05854.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Gründling A, Schneewind O. 2007. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J Bacteriol 189:2521–2530. doi: 10.1128/JB.01683-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Valente LG, Pitton M, Fürholz M, Oberhaensli S, Bruggmann R, Leib SL, Jakob SM, Resch G, Que Y-A, Cameron DR. 2021. Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis. FEMS Microbes 2:xtab003. doi: 10.1093/femsmc/xtab003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Weidenmaier C, Peschel A. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6:276–287. doi: 10.1038/nrmicro1861 [DOI] [PubMed] [Google Scholar]
  • 40. Göller PC, Elsener T, Lorgé D, Radulovic N, Bernardi V, Naumann A, Amri N, Khatchatourova E, Coutinho FH, Loessner MJ, Gómez-Sanz E. 2021. Multi-species host range of staphylococcal phages isolated from wastewater. Nat Commun 12:6965. doi: 10.1038/s41467-021-27037-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Schade J, Weidenmaier C. 2016. Cell wall glycopolymers of Firmicutes and their role as nonprotein adhesins. FEBS Lett 590:3758–3771. doi: 10.1002/1873-3468.12288 [DOI] [PubMed] [Google Scholar]
  • 42. van Dalen R, De La Cruz Diaz JS, Rumpret M, Fuchsberger FF, van Teijlingen NH, Hanske J, Rademacher C, Geijtenbeek TBH, van Strijp JAG, Weidenmaier C, Peschel A, Kaplan DH, van Sorge NM. 2019. Langerhans cells sense Staphylococcus aureus wall teichoic acid through langerin to induce inflammatory responses. mBio 10:e00330-19. doi: 10.1128/mBio.00330-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Gerlach D, Guo Y, De Castro C, Kim S-H, Schlatterer K, Xu F-F, Pereira C, Seeberger PH, Ali S, Codée J, Sirisarn W, Schulte B, Wolz C, Larsen J, Molinaro A, Lee BL, Xia G, Stehle T, Peschel A. 2018. Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 563:705–709. doi: 10.1038/s41586-018-0730-x [DOI] [PubMed] [Google Scholar]
  • 44. Koç C, Gerlach D, Beck S, Peschel A, Xia G, Stehle T. 2015. Structural and enzymatic analysis of TarM glycosyltransferase from Staphylococcus aureus reveals an oligomeric protein specific for the glycosylation of wall teichoic acid. J Biol Chem 290:9874–9885. doi: 10.1074/jbc.M114.619924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. 2021. Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589. doi: 10.1038/s41586-021-03819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. 2022. ColabFold: making protein folding accessible to all. Nat Methods 19:679–682. doi: 10.1038/s41592-022-01488-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Schultz BJ, Snow ED, Walker S. 2023. Mechanism of D-alanine transfer to teichoic acids shows how bacteria acylate cell envelope polymers. Nat Microbiol 8:1318–1329. doi: 10.1038/s41564-023-01411-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Kurokawa K, Jung DJ, An JH, Fuchs K, Jeon YJ, Kim NH, Li X, Tateishi K, Park JA, Xia G, Matsushita M, Takahashi K, Park HJ, Peschel A, Lee BL. 2013. Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin. J Biol Chem 288:30956–30968. doi: 10.1074/jbc.M113.509893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. van Dalen R, Molendijk MM, Ali S, van Kessel KPM, Aerts P, van Strijp JAG, de Haas CJC, Codée J, van Sorge NM. 2019. Do not discard Staphylococcus aureus WTA as a vaccine antigen. Nature 572:E1–E2. doi: 10.1038/s41586-019-1416-8 [DOI] [PubMed] [Google Scholar]
  • 50. Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, Schrenzel J, Lalk M, Wolz C. 2012. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 8:e1003016. doi: 10.1371/journal.ppat.1003016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Brückner R. 1992. A series of shuttle vectors for Bacillus subtilis and Escherichia coli. Gene 122:187–192. doi: 10.1016/0378-1119(92)90048-t [DOI] [PubMed] [Google Scholar]
  • 52. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10:243–245. doi: 10.1038/nm991 [DOI] [PubMed] [Google Scholar]
  • 53. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405–8410. doi: 10.1074/jbc.274.13.8405 [DOI] [PubMed] [Google Scholar]
  • 54. Chen PS, Toribara TY, Warner H. 1956. Microdetermination of phosphorus. Anal Chem 28:1756–1758. doi: 10.1021/ac60119a033 [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig. S1. mbio.01990-23-s0001.tif.

ΦE72 prevents growth of S. epidermidis 1457 wild type.

mbio.01990-23-s0001.tif (531.8KB, tif)
DOI: 10.1128/mbio.01990-23.SuF1
Fig S2. mbio.01990-23-s0002.tif.

Area-under-the-curve quantification of GroP-GroP-Glc.

mbio.01990-23-s0002.tif (485.9KB, tif)
DOI: 10.1128/mbio.01990-23.SuF2
Fig S3. mbio.01990-23-s0003.tif.

Biofilm formation.

mbio.01990-23-s0003.tif (509.9KB, tif)
DOI: 10.1128/mbio.01990-23.SuF3
Fig S4. mbio.01990-23-s0004.tif.

Electron microscopy.

DOI: 10.1128/mbio.01990-23.SuF4
Fig. S5. mbio.01990-23-s0005.tif.

Saturation of ΦE72 with purified WTA.

mbio.01990-23-s0005.tif (371.5KB, tif)
DOI: 10.1128/mbio.01990-23.SuF5
Fig. S6. mbio.01990-23-s0006.tif.

Structural prediction of the S. epidermidis TagE trimer with Alphafold2.

DOI: 10.1128/mbio.01990-23.SuF6
Fig. S7. mbio.01990-23-s0007.tif.

NMR spectra recorded for WTA isolated from S. epidermidis wild type.

DOI: 10.1128/mbio.01990-23.SuF7
Tables S1 to S4. mbio.01990-23-s0008.docx.

Bacteriophages, primers, NMR chemical shifts, and tagE conservation in S. epidermidis.

mbio.01990-23-s0008.docx (49.2KB, docx)
DOI: 10.1128/mbio.01990-23.SuF8
Supplemental material. mbio.01990-23-s0009.docx.

Legends for supplemental figures and extended descriptions of detailed methods.

DOI: 10.1128/mbio.01990-23.SuF9

Articles from mBio are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES